- $43.01bn
- $51.32bn
- $144.77bn
- 82
- 94
- 44
- 85
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 108,324 | 64,912 | 113,977 | 176,383 | 144,766 |
Cost of Revenue | |||||
Gross Profit | 4,689 | -759 | 3,129 | 16,773 | 12,932 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 104,488 | 66,491 | 111,847 | 160,886 | 132,897 |
Operating Profit | 3,836 | -1,579 | 2,130 | 15,497 | 11,869 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 3,486 | -2,010 | 1,543 | 15,307 | 11,768 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2,784 | -1,107 | 1,288 | 11,879 | 9,149 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 2,422 | -1,421 | 930 | 11,528 | 8,835 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2,415 | -1,426 | 924 | 11,485 | 8,808 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.83 | -3.53 | 2.27 | 29.3 | 24.9 |
Dividends per Share |